Robinhood shares gain on Q2 beat, as user and crypto growth accelerate
Investing.com - Integer Holding (NYSE:ITGR) received a reaffirmed Buy rating from Benchmark, which maintained its $140.00 price target on the medical device manufacturer. According to InvestingPro data, the stock currently trades near its 52-week low of $104.93, with analysts maintaining a strong consensus Buy rating of 1.4.
The company reported second-quarter 2025 results that slightly exceeded expectations, with revenue growing 11% organically to $476.0 million compared to the same period last year. Adjusted earnings reached $1.55 per share, representing a 19% increase from the second quarter of 2024. The company maintains strong financial health with a current ratio of 3.41, indicating robust liquidity to meet short-term obligations.
Benchmark had previously estimated revenues of $458.5 million, reflecting 7.2% growth, and adjusted earnings per share of $1.53. The company’s Cardio & Vascular group, its largest unit, led performance with a 24% revenue increase.
Integer Holding also updated its full-year 2025 guidance, narrowing its revenue range and raising the lower end of its adjusted earnings per share forecast by $0.10.
Despite weak share price performance year-to-date, Benchmark maintained its positive outlook on Integer Holding, citing the company’s solid revenue and earnings growth prospects.
In other recent news, Integer Holdings reported its second-quarter 2025 earnings, meeting expectations for earnings per share while surpassing revenue forecasts. The company’s revenue reached $476.5 million, reflecting a 10.8% organic growth and exceeding consensus estimates of $464.4 million. Cardio & Vascular sales saw a significant increase to $286.9 million, marking a 17.6% year-over-year organic growth. CRM & Neuromodulation sales also rose to $172.0 million, showing a 2.3% year-over-year increase. Despite these robust financial results, the company’s stock experienced a decline, influenced by market concerns over future growth prospects and competitive pressures. Citi has maintained a Buy rating on Integer Holdings, with a price target of $140.00, highlighting confidence in the company’s performance. These developments indicate ongoing investor interest and analysis of Integer Holdings’ market position and future potential.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.